JobsCoin Price Reaches $0.0004 on Exchanges (JOBS)

JobsCoin (CURRENCY:JOBS) traded 20.9% higher against the dollar during the 24 hour period ending at 16:00 PM E.T. on July 21st. During the last seven days, JobsCoin has traded up 41.8% against the dollar. JobsCoin has a market capitalization of $47,094.00 and $0.00 worth of JobsCoin was traded on exchanges in the last 24 hours. One JobsCoin coin can currently be bought for $0.0004 or 0.00000006 BTC on popular exchanges.

Here is how similar cryptocurrencies have performed during the last 24 hours:

Get JobsCoin alerts: Tao (XTO) traded up 38.7% against the dollar and now trades at $0.82 or 0.00011000 BTC. Syndicate (SYNX) traded 0.4% higher against the dollar and now trades at $0.17 or 0.00002335 BTC. Capricoin (CPC) traded 2.2% higher against the dollar and now trades at $1.18 or 0.00015914 BTC. Monkey Project (MONK) traded down 41% against the dollar and now trades at $1.30 or 0.00017500 BTC. SuperCoin (SUPER) traded 448.3% higher against the dollar and now trades at $0.0258 or 0.00000348 BTC. TrustPlus (TRUST) traded 1% higher against the dollar and now trades at $0.0351 or 0.00000474 BTC. Magnet (MAG) traded 12.5% lower against the dollar and now trades at $0.0161 or 0.00000218 BTC. Piggycoin (PIGGY) traded 0.9% higher against the dollar and now trades at $0.0009 or 0.00000012 BTC. Regalcoin (REC) traded 2% lower against the dollar and now trades at $0.0205 or 0.00000277 BTC. Centurion (CNT) traded down 11.2% against the dollar and now trades at $0.0033 or 0.00000044 BTC.

JobsCoin Coin Profile

JobsCoin is a PoW/PoS coin that uses the
X11 hashing algorithm. It launched on October 5th, 2016. JobsCoin’s total supply is 200,019,300 coins and its circulating supply is 106,019,270 coins. JobsCoin’s official Twitter account is @Jobscoin. The official website for JobsCoin is jobscoin.us.

JobsCoin Coin Trading

JobsCoin can be purchased on these cryptocurrency exchanges: YoBit. It is usually not possible to buy alternative cryptocurrencies such as JobsCoin directly using US dollars. Investors seeking to trade JobsCoin should first buy Ethereum or Bitcoin using an exchange that deals in US dollars such as Gemini, Coinbase or GDAX. Investors can then use their newly-acquired Ethereum or Bitcoin to buy JobsCoin using one of the exchanges listed above.

new TradingView.widget({ “height”: 400, “width”: 650, “symbol”: “JOBSUSD”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Roku's Speaker Deal Makes No Sense

After a blistering response to its IPO that included a 250% gain in its first two months as a publicly-traded company, Roku's (NASDAQ:ROKU) shares have noticeably cooled this year. Roku's stock currently trades hands at about $50 per share, down year-to-date and trailing the broad market as concerns about its rich valuation overshadow its strong earnings.��

CEO Anthony Wood has been aggressive in his attempts to grow the company. Last year, the company signed deals with Philips to include Roku's technology in their smart televisions; in April, the company inked a similar deal with Sanyo. And in March, the company came to an agreement with Samsung that will bring the ad-supported Roku channel to that manufacturer's line of smart televisions.

Now, Roku's back with a new hardware deal -- but this one doesn't seem as well thought out.

Image Source: Getty Images

Roku joins the speaker industry ... sort of

Roku recently announced it would bring a new hardware product to market: wireless speakers. According to the company, the devices will sell for $199.99 after Oct. 15 (earlier prices are as low as $149.99) and will include two speakers plus remotes.

However, it appears their value is limited compared to other similar offerings. Although the product takes voice commands like the Google Home and Amazon�Echo, the functionality is limited to Roku control. Additionally, the speakers' wireless-connectivity function only works with Roku TVs, which the company admits only account for 25% of the smart TV market.

At first glance, Roku's speakers bring little to the table from a differentiation perspective: their limited wireless connectivity fares poorly when compared to the host of Bluetooth-enabled systems available (although the company notes its product will reduce latency to avoid the dreaded lip-sync delay) with limited smart-speaker functions.

A razor-and-blade model doesn't need new razors

The recent investment thesis for Roku was that the company was transitioning away from a lower-margin hardware-focused company to one that would make its money via monetizing streaming delivery. A simple look into the company's first-quarter financial statements shows how the transition is paying off with higher gross profit margins.

Metric Q1 2018 Q1 2017 YOY Growth

Platform Revenue	�$75.1	�$36.4	106%
Player Revenue	�$61.5	�$63.7	(3%)
Total Revenue	�$136.6	�$100.1	36%
Platform Gross Profit	�$53.4	�$28.1	90%
Player Gross Profit	�$9.7	�$10.8	(10%)
Total Gross Profit	�$63.1	�$38.9	62%

Revenue figures in millions. Data Source: Roku's 10Q.�

Although the company has grown total revenue 36% over the prior year,� its gross profit is up 62% because all of progress it's made in the higher-margin platform division.

In the last few quarters, the company's player gross profit has decreased, a natural result of its strategy of selling more hardware at lower prices so as to profit later the higher-margin content segment. Last quarter was celebrated as the first where platform revenue exceeded player revenue. Adding a new hardware product seems antithetical to this approach.

Not a game-changer

A further interesting point is that the speakers appear to be Roku-branded products. This is a clear departure from the pattern of its recent deals with Philips and Sanyo, under which Roku outsourced the hardware production process to a third party.

Although it's likely Roku has a white-box agreement with a manufacturer that allows them to outsource the entire process, the company will still have to deal with the same issues of inventory control, defective merchandise, and returns it has with its stand-alone dongles and players.

In the end, it's likely Roku's foray into speakers will have a limited impact on its bottom line, whether positive or negative. But this appears to be an unnecessary distraction from Roku's main plans to grow its ad-based platform revenue.

Buy Rallis India; target of Rs 225: ICICI Direct

ICICI Direct's research report on Rallis India

Rallis India reported a healthy performance in Q1FY19 Consolidated revenues in Q1FY19 were at Rs 573.1 crore, up 28.6% YoY. Standalone revenues in Q1FY19 were at Rs 352.4 crore, up 42.5% YoY. Revenues of subsidiaries (Metahelix) in the seasonally important quarter i.e. Q1FY19 were at Rs 220.7 crore, up 11.4% YoY Consolidated EBITDA in Q1FY19 came in at Rs 83.1 crore with corresponding EBITDA margins at 14.5% (down 110 bps YoY). In the standalone business, Rallis continued to witness raw material pricing pressure, which was, to some extent, mitigated by operating leverage benefits with stable employee as well as other expenses EBITDA margins at subsidiaries were at 29.6% (down 120 bps YoY) Consolidated PAT in Q1FY19 came in at Rs 54.6 crore, up 20.4% YoY.

Outlook

On a consolidated basis, we expect revenues & PAT to grow at a CAGR of 10.8% & 14.2%, respectively, in FY18-20E (build in 30 bps EBITDA margin improvement in FY18-20E). We value Rallis at Rs 225 i.e. 20x P/E on FY20E EPS of Rs 11.2 and maintain our BUY rating on the stock.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Read More First Published on Jul 20, 2018 05:08 pm

Johnson & Johnson (JNJ) Slips 1.1% Ahead of Earnings: What To Watch

Shares of Johnson & Johnson (JNJ ) ticked down 1.1% during regular hours Monday, the last day of trading before it releases its latest quarterly earnings report. Investors displayed hesitation ahead of the report, but this is certainly still a stock to watch once the full results are in.

JNJ made headlines last week after it was ordered by a jury to pay $4.69 billion in a case alleging that its talcum powder product causes ovarian cancer. However, it maintains a healthy and still-growing pharmaceutical segment that has been fueled by recent acquisitions. But given concerns about drug pricing, and JNJ’s position as the first pharmaceutical company to report earnings every quarter, Tuesday’s results will have a big role in shaping investor sentiment.

According to our latest Zacks Consensus Estimates, analysts expect Johnson & Johnson to report earnings of $2.06 per share on $20.25 billion in revenue. These results would mark year-over-year growth rates of 12.6% and 7.5%, respectively.

Investors should also note that JNJ’s consensus earnings projection has trended downward over the course of the quarter. Two negative revisions have caused the Zacks Consensus Estimate to tick one cent lower in the past 90 days. It has seen a positive estimate for the next quarter and next financial year, but at the same time has seen negative estimates across the board. This mixed revision activity has contributed to the stock’s Zacks Rank #3 (Hold).

Looking at share price performance, JNJ has added 2.7% over the past year. However, the stock has performed poorly as of late, losing nearly 11% on a year-to-date basis. More recently, shares have dropped 4.6% over the trailing 12 weeks.

A strong earnings beat might be what JNJ needs in order to start turning things around. To gauge how likely the company is to outperform estimates tomorrow morning, we can turn to our exclusive Earnings ESP figure.

Zacks Earnings ESP (Expected Surprise Prediction) compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter. The Most Accurate Estimate is a version of the Zacks Consensus whose definition is related to change.

This is done because, generally speaking, when an analyst posts an estimate right before an earnings release, it means that they have fresh information which could potentially be more accurate than what analysts thought about a company two or three months ago.

A positive Earnings ESP paired with a Zacks Rank #3 (Hold) or better ranking helps us feel confident about the potential for an earnings beat. In fact, our 10-year backtest has revealed that this methodology has accurately produced a positive surprise 70% of the time.

JNJ currently has an Earnings ESP of 0.24%. This, combined with its Zacks Rank, leaves us optimistic about its chances at beating earnings estimates on Tuesday. It is also worth noting that Johnson & Johnson has not missed earnings in over five years.

Make sure to check back here for our full analysis once Johnson & Johnson reports!

Wall Street’s Next Amazon

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.

Click for details >>

D-Street Buzz: Oil & gas stocks rally with RIL up 5%; Nifty realty drags, 8K Miles Software shed

The Indian benchmark indices�including Nifty has jumped�90 points and is trading�at 11,037 mark�while�the Sensex is trading�higher�by�348 points at 36,614, reaching a new record high.

At�14:00�hrs,�the�Energy�index is outperforming the broader indices and is trading higher by�3.5 percent. From the BSE, Reliance Industries zoomed 5 percent after the company hit $100 billion market cap. MRPL, HPCL, BPCL and IOC are also trading higher by 2-4 percent.

PSU banks are also buzzing in the afternoon trade, up�1 percent led by Bank of Baroda which jumped 2 percent followed by State Bank of India, Punjab National Bank�and Canara Bank.

From the private banking space HDFC Bank, ICICI Bank, IndusInd Bank and Yes Bank are the other gainers which added up to 1 percent in the afternoon trade.

related news Trent shares jump over 7% to hit record high after Jefferies upgrades to Buy, raises target Axis Bank rallies 6% in 5 straight days, Macquarie sees further 15% upside

Realty stocks have turned weak dragged by DLF, Indiabulls Real Estate and Oberoi Realty, each shedding 2 percent while Unitech traded higher.

The top gainers among Nifty constituents are Reliance Industries which zoomed 5 percent and hitting a new record high. HPCL, BPCL,�Dr Reddy's Labs and Bajaj Finance.

The most actively traded stocks on the NSE are Reliance Industries, TCS, Infosys, Yes Bank and HDFC.

Some of the top BSE gainers�include names like GMR Infra which jumped close to 6 percent followed by Reliance Industries, Time Technoplast, Balrampur Chini and Bajaj Electricals.

Bajaj Finance, Berger Paints, HDFC Bank, Hindustan Unilever, Jubilant Foodworks, Kotak Mahindra Bank, KPIT�Tech, Mphasis and Reliance Industries�are�some�of the very�few stocks that hit fresh 52-week high in the�afternoon trade.

Adani Power is trading lower by over 7 percent from the BSE midcap space while 8K Miles Software from the BSE smallcap space is down close to 10 percent.

The breadth of the market favoured declines, with�762 stocks advancing, 948 declining and�352 remaining unchanged. On BSE,�1113 stocks advanced, 1422 declined and�143 remained unchanged.

Disclosure: Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd. First Published on Jul 12, 2018 02:29 pm

Here's Why Stitch Fix (SFIX) Stock Is Soaring Today

Shares of Stitch Fix (SFIX ) were up more than 8% through early afternoon trading Tuesday after analysts from KeyBanc Capital Markets initiated coverage on the stock with an overweight rating and a bullish price target.

Specifically, KeyBanc’s Ed Yruma acknowledged the subscription-based personal shopping service’s unique use of data.

“Stitch Fix's use of data is a significant advantage relative to the traditional apparel/retail competitive set and allows it to build a scalable, yet highly human, recommendation model,” Yruma wrote in a note to clients.

“We think share gains will continue in the core women's market, and that men's, plus, and now kids will help to further accelerate growth.”

Yruma slapped a $38 price target on SFIX, marking a 22% upside to its previous close. In a further display of how the analyst views Stitch Fix in contrast to its traditional retail peers, he also downgraded shares of Nordstrom (JWN ) and Urban Outfitters (URBN ) .

Tuesday’s gains add to Stitch Fix’s recent momentum, and the stock has now added more than 30% in the past month. SFIX has also started to generate noticeable earnings estimate revision momentum.

Within the past two months, Stitch Fix has witnessed four positive revisions to its full-year 2018 earnings estimates. The company has seen zero negative revisions to full-year estimates in that time. These positive revisions have lifted the Zacks Consensus Estimate for Stitch Fix’s 2018 earnings by six cents.

Positive earnings estimates have earned SFIX a Zacks Rank #2 (Buy). The stock is also sporting an “A” grade for Growth in our Style Scores system.

Want more market analysis from this author? Make sure to follow @Ryan_McQueeney on Twitter!

The Hottest Tech Mega-Trend of All

Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>

Best Medical Stocks To Buy For 2019

tags:CNO,APRI,LXFT,BCPC,BNCL,

By: Lars Moffatt

Introduction

The Canadian cannabis market has exploded in value in the last year due to the upcoming legalization of marijuana that is expected to become law in Canada in July of 2018. Within this market, several large corporations are acquiring smaller production companies to increase their market share and prepare for the demand that will occur due to legalization.

Today��s North Channel Investment article will look at Aurora Cannabis Inc. (OTCQX:ACBFF), and why they could be very appealing to any investor looking for a stock that has great potential for long-term growth.

Company Overview

Aurora Cannabis is a Canadian medical marijuana producer that is based out of Vancouver, British Columbia, Canada. The company specializes in the production and distribution of cannabis and cannabis oil. Aurora sells and distributes to patients who are legally entitled to medical cannabis in Canada, where the company offers secure delivery services. These services can be accessed by phone, online, and the company��s innovative mobile application. There are numerous emerging cannabis sellers and producers across North America, however, Aurora is one of Canada��s largest and fastest growing sellers of cannabis and oils. The company owns several subsidiaries that are located in Canada, United States, Germany and Australia. Some of the names of these subsidiaries are as follows:

Best Medical Stocks To Buy For 2019: CNO Financial Group, Inc.(CNO)

Advisors' Opinion:

• [By Stephan Byrd]

  CNO Financial Group (NYSE:CNO) hit a new 52-week high and low during mid-day trading on Tuesday . The company traded as low as $19.32 and last traded at $19.49, with a volume of 149704 shares traded. The stock had previously closed at $19.81.

• [By Shane Hupp]

  Coin(O) (CURRENCY:CNO) traded flat against the U.S. dollar during the twenty-four hour period ending at 21:00 PM ET on May 12th. One Coin(O) coin can now be purchased for about $0.0021 or 0.00000025 BTC on popular exchanges. Coin(O) has a market cap of $222,284.00 and $40.00 worth of Coin(O) was traded on exchanges in the last 24 hours. Over the last seven days, Coin(O) has traded 21.2% lower against the U.S. dollar.

• [By Joseph Griffin]

  CNO Financial Group (NYSE:CNO) announced a quarterly dividend on Thursday, May 10th, Wall Street Journal reports. Stockholders of record on Monday, June 11th will be given a dividend of 0.10 per share by the financial services provider on Monday, June 25th. This represents a $0.40 annualized dividend and a dividend yield of 1.96%. The ex-dividend date of this dividend is Friday, June 8th. This is a boost from CNO Financial Group’s previous quarterly dividend of $0.09.

Best Medical Stocks To Buy For 2019: Apricus Biosciences, Inc(APRI)

Advisors' Opinion:

• [By Chris Lange]

  Apricus Biosciences Inc. (NASDAQ: APRI) has a PDUFA goal date for completion of the FDA��s review of the Vitaros NDA set on February 17. Vitaros is a novel, on-demand topical cream for the treatment of erectile dysfunction (ED) and a new potential entrant into the U.S. ED treatment market. So far Vitaros has been approved in Canada, Mexico and certain countries in Europe, Latin America and the Middle East. Shares of Apricus were last seen at $2.22, with a 52-week range of $0.86 to $3.49 and a consensus price target of $3.50.

• [By Paul Ausick]

  Apricus Biosciences Inc. (NASDAQ: APRI) also dropped about 38% Monday to post a new 52-week low of $0.26. Shares closed at $0.42 on Friday and the stock’s 52-week high is $3.34. Volume was more than three times the daily average of around 1.4 million shares. The company is considering its options after the U.S. FDA directed the firm to develop a new formulation for its erectile dysfunction drug, Vitaros.

• [By William Romov]

  California-based Apricus Biosciences Inc. (Nasdaq: APRI) develops treatments in the areas of urology and rheumatology. Its lead product, Vitaros, is a topically applied cream for the treatment of erectile dysfunction (ED).

Best Medical Stocks To Buy For 2019: Luxoft Holding, Inc.(LXFT)

Advisors' Opinion:

• [By Logan Wallace]

  Luxoft (NYSE: LXFT) and Zscaler (NASDAQ:ZS) are both computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, dividends, risk and earnings.

• [By Lisa Levin]

  Luxoft Holding, Inc. (NYSE: LXFT) was down, falling around 26 percent to $32.15. Luxoft posted in-line Q4 earnings, but issued weak forecast for the current quarter.

• [By Shane Hupp]

  Luxoft Holding Inc (NYSE:LXFT) has been given an average rating of “Hold” by the fourteen brokerages that are presently covering the company, Marketbeat Ratings reports. Three investment analysts have rated the stock with a sell recommendation, six have given a hold recommendation and five have issued a buy recommendation on the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $53.33.

• [By Motley Fool Staff]

  Luxoft Holding (NYSE:LXFT) Q4 2018 Earnings Conference CallMay. 24, 2018 8:00 a.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Steve Symington]

  Shares of Luxoft Holding Inc. (NYSE:LXFT) were down 21.3% as of 11:30 a.m. EDT Thursday after the software development company announced strong quarterly results, but followed with light guidance.

Best Medical Stocks To Buy For 2019: Balchem Corporation(BCPC)

Advisors' Opinion:

• [By Stephan Byrd]

  Balchem Co. (NASDAQ:BCPC) shares reached a new 52-week high and low on Wednesday . The stock traded as low as $96.61 and last traded at $96.33, with a volume of 2460 shares traded. The stock had previously closed at $95.08.

• [By Logan Wallace]

  JPMorgan Chase & Co. boosted its position in shares of Balchem Co. (NASDAQ:BCPC) by 20.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 73,196 shares of the basic materials company’s stock after buying an additional 12,487 shares during the period. JPMorgan Chase & Co.’s holdings in Balchem were worth $5,985,000 at the end of the most recent quarter.

• [By Logan Wallace]

  Shares of Balchem Co. (NASDAQ:BCPC) hit a new 52-week high and low on Monday . The company traded as low as $97.20 and last traded at $96.87, with a volume of 107919 shares. The stock had previously closed at $96.52.

• [By Travis Hoium]

  Nearly every business Balchem�(NASDAQ:BCPC) is in has seen strong growth in 2018, and that's driving the company's financial results higher. Fracking is seeing the biggest growth, but human and animal health continue to be great businesses for the company.�

• [By Max Byerly]

  Carillon Tower Advisers Inc. boosted its stake in Balchem Co. (NASDAQ:BCPC) by 656.3% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 55,180 shares of the basic materials company’s stock after purchasing an additional 47,884 shares during the period. Carillon Tower Advisers Inc. owned about 0.17% of Balchem worth $4,510,000 at the end of the most recent reporting period.

Best Medical Stocks To Buy For 2019: Beneficial Mutual Bancorp Inc.(BNCL)

Advisors' Opinion:

• [By Joseph Griffin]

  Media coverage about Beneficial Bancorp (NASDAQ:BNCL) has trended positive recently, according to Accern. Accern identifies positive and negative news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Beneficial Bancorp earned a news impact score of 0.38 on Accern’s scale. Accern also gave media headlines about the bank an impact score of 45.8699493506664 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

• [By Ethan Ryder]

  BidaskClub upgraded shares of Beneficial Bancorp (NASDAQ:BNCL) from a sell rating to a hold rating in a report released on Tuesday morning.

  Shares of Beneficial Bancorp opened at $16.35 on Tuesday, MarketBeat.com reports. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.51. The company has a market capitalization of $1.23 billion, a P/E ratio of 31.44 and a beta of 0.55. Beneficial Bancorp has a fifty-two week low of $14.40 and a fifty-two week high of $17.50.

• [By Logan Wallace]

  Beneficial Bancorp (NASDAQ: BNCL) and Home Bancorp (NASDAQ:HBCP) are both small-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, analyst recommendations, risk, dividends and valuation.

• [By Joseph Griffin]

  Beneficial Bancorp Inc (NASDAQ:BNCL) Director Thomas J. Lewis sold 973 shares of the company’s stock in a transaction dated Wednesday, May 30th. The stock was sold at an average price of $16.50, for a total value of $16,054.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Top 5 Warren Buffett Stocks To Watch For 2019

tags:FORM,SHPG,SOL,IBKR,ENX,

Warren Buffett believes trying to time the market is a waste of time and hazardous to investment success.

The Oracle of Omaha explained why investors should avoid market predictions during Berkshire Hathaway's annual shareholder meeting in 1994, obtained through the CNBC Warren Buffett archive.

"I never have an opinion about the market because it wouldn't be any good and it might interfere with the opinions we have that are good," Buffett said. "If we're right about a business, if we think a business is attractive, it would be very foolish for us to not take action on that because we thought something about what the market was going to do. �� If you're right about the businesses, you'll end up doing fine."

Bill Pugliano | Getty Images Warren Buffett

Buffett said it is a "mistake" to not invest in a great company due to market worries.

Top 5 Warren Buffett Stocks To Watch For 2019: FormFactor, Inc.(FORM)

Advisors' Opinion:

• [By Lisa Levin]

  Check out these big penny stock gainers and losers

  Losers World Fuel Services Corporation (NYSE: INT) tumbled 18 percent to $22.90 following Q1 results. Biglari Holdings Inc. (NYSE: BH) fell 17.4 percent to $349.52. Washington Prime Group will replace Biglari Holdings in the S&P SmallCap 600 on Tuesday, May 1. Flex Ltd. (NASDAQ: FLEX) dipped 15.7 percent to $14.03 after a mixed fourth quarter report. FormFactor, Inc. (NASDAQ: FORM) fell 15.3 percent to $11.65. FormFactor is expected to release Q1 results on May 2. Data I/O Corporation (NASDAQ: DAIO) dropped 14.3 percent to $6.24 following Q1 results. National Instruments Corporation (NASDAQ: NATI) fell 14.3 percent to $ 42.34 after reporting Q1 results. United States Steel Corporation (NYSE: X) dipped 14.2 percent to $32.37 following Q1 results. Civeo Corporation (NYSE: CVEO) dropped 13.5 percent to $3.33. Civeo posted a Q1 loss of $0.42 per share on sales of $101.504 million. athenahealth, Inc. (NASDAQ: ATHN) fell 12.4 percent to $125.310 after reporting Q1 results. Charter Communications, Inc. (NASDAQ: CHTR) shares tumbled 12.1 percent to $262.06 as the company posted Q1 results. Value Line, Inc. (NASDAQ: VALU) fell 11.3 percent to $19.10. Federated Investors, Inc. (NYSE: FII) shares dropped 11.2 percent to $27.605 after the company posted downbeat quarterly earnings. AV Homes, Inc. (NASDAQ: AVHI) declined 10.7 percent to $17.20 following Q1 results. CalAmp Corp. (NASDAQ: CAMP) dropped 9.4 percent to $21.01 after reporting Q4 results. Tandem Diabetes Care, Inc. (NASDAQ: TNDM) shares fell 8.9 percent to $7.280 following mixed Q1 results. Sony Corporation (NYSE: SNE) shares fell 8.4 percent to $45.97 after reporting Q4 results. LogMeIn Inc (NASDAQ: LOGM) fell 8.2 percent to $109.825. LogMeIn reported upbeat earnings for its first quarter, but issued weak second quarter and FY18 earning guidance. Eleven Biotherapeutics, Inc. (NASDAQ: EBIO
• [By Ethan Ryder]

  Get a free copy of the Zacks research report on FormFactor (FORM)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Warren Buffett Stocks To Watch For 2019: Shire plc(SHPG)

Advisors' Opinion:

• [By ]

  Allergan's (NYSE: AGN) recent decision to back out of a bidding war for Shire (Nasdaq: SHPG) gives me new confidence in the company. While the acquisition could have given Allergan a diversified rare-disease portfolio of drugs, it would have meant a debt-binging acquisition and I'm always hesitant around the 'winner' of bidding wars.

• [By Todd Campbell]

  Unfortunately for investors, June's discovery wasn't exciting enough for Sangamo partners Biogen (NASDAQ:BIIB) and Shire (NASDAQ:SHPG). In 2015, Biogen announced a delay to its beta-thalassemia and sickle-cell disease treatment program with Sangamo. And then Shire, a Sangamo collaboration partner since 2012, walked away from Sangamo's hemophilia program.

• [By Lisa Levin] Gainers Sanmina Corp (NASDAQ: SANM) shares rose 15.2 percent to $31.90 in pre-market trading as the company reported stronger-than-expected earnings for its second quarter on Monday. Cadence Design Systems, Inc. (NASDAQ: CDNS) rose 12.4 percent to $41.30 in pre-market trading after the company posted upbeat Q1 results and issued a strong Q2 forecast. Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) rose 10.8 percent to $8.75 in pre-market trading. Mitel Networks Corporation (NASDAQ: MITL) rose 8.8 percent to $11.05 in pre-market trading after the company agreed to be acquired by affiliates of Searchlight Capital Partners for $2.0 billion. Galectin Therapeutics, Inc. (NASDAQ: GALT) rose 7.3 percent to $3.70 in pre-market trading. Riot Blockchain, Inc. (NASDAQ: RIOT) shares rose 6.9 percent to $7.00 in pre-market trading after declining 1.50 percent on Monday. Hallmark Financial Services, Inc. (NASDAQ: HALL) rose 6.5 percent to $10.68 in pre-market trading. Boot Barn Holdings, Inc. (NYSE: BOOT) rose 5.2 percent to $20.40 in pre-market trading after gaining 4.53 percent on Monday. New Oriental Education & Technology Group Inc. (NYSE: EDU) rose 5 percent to $91.16 in pre-market trading after reporting Q3 results. Shire plc (NASDAQ: SHPG) rose 5 percent to $167.98 in pre-market trading after Bloomberg reported that Takeda is nearing a preliminary agreement to acquire Shire after sweetened bid. Outfront Media Inc. (NYSE: OUT) shares rose 5 percent to $19.00 in pre-market trading. Geron Corporation (NASDAQ: GERN) rose 4.3 percent to $4.18 in pre-market trading after gaining 5.80 percent on Monday. SAP SE (NYSE: SAP) rose 3.7 percent to $109.80 in pre-market trading after the company posted strong quarterly results and raised its outlook for the year. Golden Ocean Group Limited (NASDAQ: GOGL) shares rose 3.7 percent to $8.70 in pre-market trading after gaining 1.45 percent on Monday. Deutsche Bank Aktiengesellschaft (NYSE: D

Top 5 Warren Buffett Stocks To Watch For 2019: Renesola Ltd.(SOL)

Advisors' Opinion:

• [By Joseph Griffin]

  These are some of the media headlines that may have impacted Accern’s scoring:

  Get ReneSola alerts: ReneSola Sells North Carolina Solar Project To Greenbacker (solarindustrymag.com) ReneSola (SOL) Rating Increased to Neutral at Roth Capital (americanbankingnews.com) ReneSola (SOL) Q1 Earnings in Line, Revenues Top Estimates (zacks.com) ReneSola’s (SOL) CEO Xianshou Li on Q1 2018 Results – Earnings Call Transcript (seekingalpha.com) ReneSola (SOL) Releases Earnings Results (americanbankingnews.com)

  Shares of ReneSola traded up $0.08, hitting $2.76, during trading on Friday, Marketbeat.com reports. The stock had a trading volume of 124,969 shares, compared to its average volume of 108,565. The firm has a market capitalization of $102.11 million, a PE ratio of 21.23 and a beta of 2.05. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.36. ReneSola has a 12 month low of $2.12 and a 12 month high of $3.79.

Top 5 Warren Buffett Stocks To Watch For 2019: Interactive Brokers Group, Inc.(IBKR)

Advisors' Opinion:

• [By Stephan Byrd]

  Interactive Brokers Group (NASDAQ: IBKR) and Charles Schwab Co. Common Stock (NYSE:SCHW) are both large-cap finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, valuation, earnings, analyst recommendations, profitability and risk.

• [By Dustin Blitchok]

  The European Union’s General Data Protection Regulation takes effect May 25, and Steve Sanders, the executive vice president of marketing and product development at Interactive Brokers (NASDAQ: IBKR), described it as the “bane of my existence.” Compliance with the regulations is taking resources from other products at the online brokerage, he said.

• [By Joseph Griffin]

  Here are some of the headlines that may have effected Accern Sentiment Analysis’s analysis:

  Get Interactive Brokers Group alerts: What Could Attract Investors to Interactive Brokers (finance.yahoo.com) Reviewing Charles Schwab (SCHW) and Interactive Brokers Group (IBKR) (americanbankingnews.com) Interactive Brokers Group (IBKR) Presents At Sandler O’Neill’s Global Exchange And Brokerage Conference – Slideshow (seekingalpha.com) Should You Invest In The Financial Stock Interactive Brokers Group Inc (NASDAQ:IBKR)? (finance.yahoo.com) Interactive Brokers Welcomes New Bond Disclosure Rules (finance.yahoo.com)

  Shares of Interactive Brokers Group traded up $1.20, reaching $71.38, during midday trading on Friday, according to MarketBeat Ratings. 1,131,168 shares of the company were exchanged, compared to its average volume of 859,815. The stock has a market cap of $29.39 billion, a PE ratio of 46.65, a PEG ratio of 1.65 and a beta of 0.95. Interactive Brokers Group has a one year low of $36.23 and a one year high of $80.32.

• [By Max Byerly]

  Compass Point started coverage on shares of Interactive Brokers Group (NASDAQ:IBKR) in a research note published on Tuesday. The brokerage issued a neutral rating and a $74.00 price target on the financial services provider’s stock.

• [By Logan Wallace]

  Get a free copy of the Zacks research report on Interactive Brokers Group (IBKR)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Warren Buffett Stocks To Watch For 2019: Eaton Vance New York Municipal Bond Fund(ENX)

Advisors' Opinion:

• [By Logan Wallace]

  Eaton Vance New York Municipal Bond Fund (NYSEAMERICAN:ENX) announced a monthly dividend on Monday, June 4th, Wall Street Journal reports. Shareholders of record on Friday, June 22nd will be given a dividend of 0.0448 per share on Friday, June 29th. This represents a $0.54 annualized dividend and a yield of 4.77%. The ex-dividend date of this dividend is Thursday, June 21st.

• [By Logan Wallace]

  Eaton Vance New York Municipal Bond Fund (NYSEAMERICAN:ENX) announced a monthly dividend on Thursday, July 5th, Wall Street Journal reports. Investors of record on Tuesday, July 24th will be paid a dividend of 0.0448 per share on Tuesday, July 31st. This represents a $0.54 dividend on an annualized basis and a dividend yield of 4.75%. The ex-dividend date of this dividend is Monday, July 23rd.

• [By Joseph Griffin]

  Euronext Amsterdam (EPA:ENX) has been assigned a €51.00 ($60.71) price target by investment analysts at UBS in a note issued to investors on Wednesday, www.boersen-zeitung.de reports. The firm presently has a “sell” rating on the stock. UBS’s target price would suggest a potential downside of 15.63% from the stock’s current price.

Over 160 stocks hit fresh 52-week low on BSE; DEN Networks, Hathway, BHEL, Andhra Bank top losers

The Indian benchmark indices are trading on a positive note this Friday afternoon�with the Nifty�adding�47�points and is trading at 10,796 mark. The Sensex is trading higher by�147�points at 35,722.

The breadth of the market favoured�advances, with�1056�stocks advancing, 600�declining and�409�remaining unchanged. On BSE,�1280�stocks advanced, 938�declined and�119�remained unchanged.

However, in the BSE, over 160 stocks have hit fresh 52-week low including names like Conart Engineers which is down close to 10 percent followed by Hathway Cable, DEN Networks, Ujaas Energy, JBF Industries, Kwality, Visa Steel, SRS, Finolex Industries, EROS International, Dena Bank, PTC India Financial, INOX Wind, Andhra Bank, Vedanta, HDIL, Capital First, BHEL and REC among others.

However, BSE Auto and BSE Capital goods has gained over 1 percent led by stocks like Hero Moto, Bajaj Auto, Ashok Leyland, Bharat Forge, Motherson Sumi and Tata Motors among others.

related news D-Street Buzz: Auto stocks rally with Tata Motors, Hero Moto up 3-4%; Asian Paints hits new 52-week high, Adani Power spikes Kotak Securities upgrades Ashok Leyland to buy; slowdown concerns is overdone

Capital good stocks are also up led by BEML, Bharat Electronics, CG Power, Greaves Cotton,�Larsen & Toubro and V-Guard Industries among others.

Vakrangee from the BSE midcap space is trading lower by 5 percent while Hathway Cable is down over 10 percent which is the top smallcap loser.

Den Networks which is trading lower by 6 percent, Vakrangee shedding 5 percent followed by Kwality and IL&FS Transportation are the top stocks to have hit fresh 52-week low in the afternoon trade. First Published on Jul 6, 2018 12:14 pm

Nebula Acquisition Corp’s (NEBUU) Lock-Up Period Set To End on July 9th

Nebula Acquisition’s (NASDAQ:NEBUU) lock-up period will end on Monday, July 9th. Nebula Acquisition had issued 25,000,000 shares in its IPO on January 10th. The total size of the offering was $250,000,000 based on an initial share price of $10.00. Shares of the company owned by major shareholders and company insiders will be eligible for trade following the expiration of the lock-up period.

Nebula Acquisition opened at $10.07 on Wednesday, according to Marketbeat.com. Nebula Acquisition has a 12 month low of $9.96 and a 12 month high of $10.15.

Get Nebula Acquisition alerts:

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Park West Asset Management LLC purchased a new stake in Nebula Acquisition in the 1st quarter valued at $20,240,000. Highbridge Capital Management LLC purchased a new stake in shares of Nebula Acquisition during the 1st quarter valued at $13,098,000. The Manufacturers Life Insurance Company purchased a new stake in shares of Nebula Acquisition during the 1st quarter valued at $12,690,000. OZ Management LP purchased a new stake in shares of Nebula Acquisition during the 1st quarter valued at $10,120,000. Finally, Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp purchased a new stake in shares of Nebula Acquisition during the 1st quarter valued at $4,554,000.

About Nebula Acquisition

Nebula Acquisition Corporation is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company intends to focus its search for a target business in the technology industry.